Copelink Blog

In a recent article in The New York Times, the ongoing chemotherapy drug shortage many cancer patients and their loved ones have faced over the last year was brought into focus. The piece highlights a growing crisis in the generic drug industry and features insights from Danielle Saff, LCSW, an oncology social worker and the Older Adult Program Manager/Clinical Supervisor with CancerCare.

The article, written by Christina Jewett, reveals a distressing reality of patients being forced to face cancer treatment without essential drugs. This shortage represents a logistical failure as well as a profound emotional burden for those seeking cancer treatment. The scarcity of medications like cisplatin and carboplatin, critical in treating various cancers, has led to a dire situation in medical facilities across the country.

In the article, Danielle provides a unique perspective on the diverse emotional impacts of this crisis on patients.

“Some people with cancer were too focused on paying rent or feeding a family to fight for the medications they desperately needed,” she said.

CancerCare’s mention in The New York Times not only raises awareness of the emotional ramifications of the drug shortage but also highlights the organization’s commitment to supporting cancer patients and their loved ones every step of the way. As CancerCare continues to advocate for patients, this article serves as a crucial reminder of the many hardships faced by people impacted by cancer, beyond just the physical, emotional and financial challenges – they must also navigate a health care system that can sometimes fail the very individuals it seeks to heal.

As always, CancerCare is available to support people diagnosed with cancer, their caregivers and loved ones and the bereaved through counseling, support groups, education and coping workshops, resource navigation and financial assistance. Call our toll-free Hopeline at 800‑813‑HOPE (4673) to speak with a professional oncology social worker today.